Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Acorda Therapeutics Inc. (ACOR)

1.32   -0.05 (-3.65%) 02-26 16:00
Open: 1.38 Pre. Close: 1.37
High: 1.45 Low: 1.3
Volume: 1,835,191 Market Cap: 63M
Acorda Therapeutics Inc is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of neurological disorders.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.459 - 1.473 1.473 - 1.482
Low: 1.273 - 1.289 1.289 - 1.3
Close: 1.301 - 1.328 1.328 - 1.345

Technical analysis

as of: 2020-02-26 4:25:19 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 2.42     One year: 2.98
Support: Support1: 1.30    Support2: 1.08
Resistance: Resistance1: 2.07    Resistance2: 2.55
Pivot: 1.76
Moving Average: MA(5): 1.43     MA(20): 1.84
MA(100): 2.06     MA(250): 5.75
MACD: MACD(12,26): -0.19     Signal(9): -0.12
Stochastic oscillator: %K(14,3): 2.73     %D(3): 2.18
RSI: RSI(14): 27.65
52-week: High: 15.41  Low: 1.30  Change(%): -91.0
Average Vol(K): 3-Month: 272730  10-Days: 239279

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ACOR has closed above bottom band by 9.7%. Bollinger Bands are 28.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) Co-Diagnostics Inc (NASDAQ: CODX )(received CE mark for its coronavirus test) COLLPLANT BIOTE/S ADR (NASDAQ: CLGN ) Gilead Sciences, Inc. (NASDAQ: GILD )(reacted to a statement from WHO that its experimental drug remdesivir could be the one drug that may have efficacy) NGM Biopharmaceuticals Inc (NASDAQ: NGM )( reacted to positive readout for its NASH drug) PAVmed Inc (NASDAQ: PAVM ) TELA Bio Inc (NASDAQ: TELA ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Feb. 24) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Acorda Therapeutics Inc (NASDAQ: ACOR ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) AngioDynamics, Inc. (NASDAQ: ANGO ) BioSig Technologies Inc (NASDAQ: BSGM ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) Endologix, Inc.

Acorda (ACOR) Q4 Earnings Top Estimates, Revenues Fall Y/Y
Acorda (ACOR) beat earnings and revenue estimates in the fourth quarter of 2019.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 48.03
Shares Float (M) 43.11
% Held by Insiders 1.49
% Held by Institutions 125.47
Shares Short (K) 13740
Shares Short P. Month (K)

Stock Financials

EPS -6.929
Book Value (p.s.) 5.920
PEG Ratio -0.04
Profit Margin -155.89
Operating Margin -56.76
Return on Assets (ttm) -6.8
Return on Equity (ttm) -74.8
Qtrly Rev. Growth -66.6
Gross Profit (p.s.) 7.748
Sales Per Share
EBITDA (p.s.) -1.931
Qtrly Earnings Growth
Operating Cash Flow (M) -129.08
Levered Free Cash Flow (M) -143.00

Stock Valuations

P/E -0.19
P/E Growth Ratio -0.04
P/BV 0.22
P/S 0.29
P/CF -0.49

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.